Published in CMAJ on January 10, 2012
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88
Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med (2009) 3.12
Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. Can J Gastroenterol (2004) 1.59
Helicobacter pylori in First Nations and recent immigrant populations in Canada. Can J Gastroenterol (2012) 1.38
The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. Am J Trop Med Hyg (2009) 1.22
Development of guidelines for recently arrived immigrants and refugees to Canada: Delphi consensus on selecting preventable and treatable conditions. CMAJ (2010) 1.06
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol (2009) 5.83
Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol (2004) 5.09
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol (2009) 3.88
Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol (2004) 2.86
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol (2004) 2.80
Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev (2013) 2.53
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol (2008) 2.02
Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr (2011) 1.95
A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Am J Gastroenterol (2005) 1.94
World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis (2010) 1.82
The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner. Immunity (2013) 1.71
Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. Can J Gastroenterol (2004) 1.59
Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev (2015) 1.58
Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2008) 1.56
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis (2010) 1.52
Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol (2010) 1.49
Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper. Can J Gastroenterol (2006) 1.49
The cost of an upper gastroduodenal endoscopy: an activity-based approach. Can J Gastroenterol (2002) 1.46
Effect of Helicobacter pylori's vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy (2009) 1.45
Reproducibility of retinal circulation measurements obtained using laser speckle flowgraphy-NAVI in patients with glaucoma. Clin Ophthalmol (2011) 1.40
World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol (2012) 1.39
Helicobacter pylori in First Nations and recent immigrant populations in Canada. Can J Gastroenterol (2012) 1.38
Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig Dis Sci (2004) 1.37
Survey of access to gastroenterology in Canada: the SAGE wait times program. Can J Gastroenterol (2010) 1.37
Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis (2005) 1.34
Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res (2009) 1.28
Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol (2003) 1.27
Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases. Infect Immun (2002) 1.17
Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluation. Can J Gastroenterol (2005) 1.17
Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement. Can J Gastroenterol (2008) 1.15
Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol (2013) 1.15
Significant correlations between optic nerve head microcirculation and visual field defects and nerve fiber layer loss in glaucoma patients with myopic glaucomatous disk. Clin Ophthalmol (2011) 1.14
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol (2006) 1.13
Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology (2012) 1.12
Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies. Ann Med (2006) 1.11
A Canadian clinical practice algorithm for the management of patients with nonvariceal upper gastrointestinal bleeding. Can J Gastroenterol (2004) 1.10
World Gastroenterology Organisation global guideline: Constipation--a global perspective. J Clin Gastroenterol (2011) 1.10
Predicting which patients can undergo upper endoscopy comfortably without conscious sedation. Gastrointest Endosc (2002) 1.07
Fractures around the lateral cortical hinge after a medial opening-wedge high tibial osteotomy: a new classification of lateral hinge fracture. Arthroscopy (2011) 1.05
Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial. Am J Gastroenterol (2006) 1.04
Management of patients with nonvariceal upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2011) 1.03
Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun (2004) 1.03
Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol (2005) 1.01
Fascination with bacteria-triggered cell death: the significance of Fas-mediated apoptosis during bacterial infection in vivo. Microbes Infect (2003) 0.97
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease. BMC Gastroenterol (2005) 0.97
Autophagy as an emerging dimension to adaptive and innate immunity. Semin Immunol (2009) 0.96
Pathogenesis of Helicobacter pylori infection. Helicobacter (2013) 0.96
Novel approaches to inhibition of gastric acid secretion. Curr Gastroenterol Rep (2010) 0.96
Interleukin-1 receptor phosphorylation activates Rho kinase to disrupt human gastric tight junctional claudin-4 during Helicobacter pylori infection. Cell Microbiol (2010) 0.93
Modulation of autophagy by Helicobacter pylori and its role in gastric carcinogenesis. Trends Microbiol (2013) 0.92
Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint. Cancer Epidemiol Biomarkers Prev (2008) 0.89
Helicobacter pylori infection and childhood. Helicobacter (2010) 0.88
Recent advances in Helicobacter pylori pathogenesis. Curr Opin Gastroenterol (2012) 0.88
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Health Qual Life Outcomes (2005) 0.88
A randomized multicenter trial to evaluate simple utility elicitation techniques in patients with gastroesophageal reflux disease. Med Care (2004) 0.88
Effect of topical tafluprost on optic nerve head blood flow in patients with myopic disc type. J Glaucoma (2013) 0.88
Population structure of Anopheles arabiensis on La Réunion island, Indian Ocean. Am J Trop Med Hyg (2005) 0.87
Helicobacter pylori infection and gastric cancer: host, bug, environment, or all three? Curr Gastroenterol Rep (2004) 0.86
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation. Pharmacoeconomics (2007) 0.85
Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. Can J Gastroenterol Hepatol (2014) 0.85
The role of dermatopontin in the stromal organization of the cornea. Invest Ophthalmol Vis Sci (2006) 0.85
Analysis of the population structure of Anopheles funestus (Diptera: Culicidae) from western and coastal Kenya using paracentric chromosomal inversion frequencies. J Med Entomol (2002) 0.84
Detergent-resistant microdomains mediate activation of host cell signaling in response to attaching-effacing bacteria. Lab Invest (2009) 0.83
Generation of 3D retina-like structures from a human retinal cell line in a NASA bioreactor. Cell Transplant (2003) 0.83
Helicobacter pylori disrupts STAT1-mediated gamma interferon-induced signal transduction in epithelial cells. Infect Immun (2004) 0.83
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori. Can J Gastroenterol (2003) 0.83
Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect Immun (2011) 0.83
Crohn disease ATG16L1 polymorphism increases susceptibility to infection with Helicobacter pylori in humans. Autophagy (2012) 0.83
Changeable reactivity of ketyl radicals derived from 2-bromomethyl-2-(3-butenyl)benzocyclic-1-alkanones depending on electron transfer conditions employed. Chem Commun (Camb) (2002) 0.81
A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care. Can J Gastroenterol (2010) 0.81
Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines. Digestion (2009) 0.81
Construction of a part of a 3-hydroxypropionate cycle for heterologous polyketide biosynthesis in Escherichia coli. Biochemistry (2012) 0.81
Helicobacter pylori infection induces interleukin-18 production in gastric epithelial (AGS) cells. Dig Dis Sci (2005) 0.80
Helicobacter pylori inhibits dendritic cell maturation via interleukin-10-mediated activation of the signal transducer and activator of transcription 3 pathway. J Innate Immun (2014) 0.80
Helicobacter pylori infection interferes with epithelial Stat6-mediated interleukin-4 signal transduction independent of cagA, cagE, or VacA. J Immunol (2003) 0.80
Methods to monitor autophagy in H. pylori vacuolating cytotoxin A (VacA)-treated cells. Autophagy (2010) 0.80
Endoscopy of the esophagus in gastroesophageal reflux disease: are we losing sight of symptoms? Another perspective. Dis Esophagus (2009) 0.79
Autophagy: healthy eating and self-digestion for gastroenterologists. J Pediatr Gastroenterol Nutr (2008) 0.79
An update on anti-Helicobacter pylori treatment in children. Can J Gastroenterol (2005) 0.79
Helicobacter pylori and the prevention of gastric cancer. Can J Gastroenterol (2004) 0.79
A glossary of economic terms. Eur J Gastroenterol Hepatol (2004) 0.78
Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. J Clin Epidemiol (2008) 0.78
Treat the patients' main dyspepsia complaint, not the ROME criteria. Am J Gastroenterol (2004) 0.78
Acid suppression for reflux disease: "off-the-peg" or a tailored approach? Clin Gastroenterol Hepatol (2011) 0.77
Risks and benefits of Helicobacter pylori eradication: current status. Can J Gastroenterol (2002) 0.77
Etiology of dyspepsia: implications for empirical therapy. Can J Gastroenterol (2002) 0.77
World Gastroenterology Organisation global guidelines on obesity. J Clin Gastroenterol (2012) 0.77
Modulation of host cell signal transduction pathways by Helicobacter pylori infection. Can J Gastroenterol (2005) 0.77